TY  - GEN 
AU  - Muñoz Barba, Daniel
AU  - García Moronta, Carmen
AU  - Soto Moreno, Alberto
AU  - Sánchez Díaz, Manuel
AU  - Arias Santiago, Salvador
PY  - 2025
UR  - https://hdl.handle.net/10481/107805
AB  - Background/Objectives: Baricitinib, a selective Janus kinase (JAK) 1 and 2 inhibitor, has
recently emerged as a therapeutic option for patients with severe alopecia areata (AA).
The aim of this study was to identify clinical and biological...
LA  - eng
PB  - MDPI
KW  - Alopecia Areata
KW  - Baricitinib
KW  - Early responders
TI  - Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
DO  - 10.3390/jcm14207312
ER  -